Molecular point-of-care testing versus conventional RT-PCR for influenza A: Diagnostic performance, clinical decision-making, and costs in a tertiary hospital in Shenzhen, China.

Published 09/16/2026

Research record: Molecular point-of-care testing versus conventional RT-PCR for influenza A: Diagnostic performance, clinical decision-making, and costs in a tertiary hospital in Shenzhen, China.

Published in J Clin Virol; first publication date 2026-09-16. PMID 42759342.

This literature update records publication metadata from Europe PMC. Consult the original publication for its methods, findings and limitations.

Read the original publication on PubMed

Talk to a Specialist Browse all insights

Review and references

Source

Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.

Published

2026-09-16

Updated

2026-10-19

Disclaimer

professional use

References